Loading…
Loading grant details…
| Funder | Wellcome Trust |
|---|---|
| Recipient Organization | Cardiff University |
| Country | United Kingdom |
| Start Date | Oct 01, 2023 |
| End Date | Sep 30, 2031 |
| Duration | 2,921 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | 226510 |
Neurodevelopmental disorders (NDDs), including intellectual disability, epilepsy, autism spectrum disorder and schizophrenia affect >5% of the global population. However, the cause of most NDDs remains unknown, making it difficult to diagnose, mitigate or treat.
Emerging evidence suggest that somatic mutations which occur during embryonic development represent one of the missing pieces in this puzzle but how and where these mutations occur remain unclear. Dysfunction in UPF1 and UPF3B are associated with inherited risk for developing NDDs.
Recently, I have discovered that these two genes suppress mutations at DNA double-strand breaks (DSBs) by stimulating the formation of R-loops, enigmatic three-stranded structures containing DNA-RNA hybrids.
This finding suggests that reduced R-loop-dependent DSB repair (DSBR) may exacerbate the accumulation of somatic mutations in developing embryo, disrupting genes required for neurodevelopment, and presents us with an innovative way to identify these mutations.
I aim to investigate the mechanism of R-loop-dependent DSBR, and its role in suppressing mutations and neuronal dysfunction, by exploiting recent advances in single-molecule long-read sequencing, DSB mapping and stem cell technologies.
This proposal will examine a novel mechanism for increased mental health risk to uncover new somatic mutations, risk factors or aetiology, contributing to improvement in diagnosis or mitigation of NDDs.
Cardiff University
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant